Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0331710B2 - - Google Patents
[go: Go Back, main page]

JPH0331710B2 - - Google Patents

Info

Publication number
JPH0331710B2
JPH0331710B2 JP20544089A JP20544089A JPH0331710B2 JP H0331710 B2 JPH0331710 B2 JP H0331710B2 JP 20544089 A JP20544089 A JP 20544089A JP 20544089 A JP20544089 A JP 20544089A JP H0331710 B2 JPH0331710 B2 JP H0331710B2
Authority
JP
Japan
Prior art keywords
chloroform
residue
difluoro
water
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP20544089A
Other languages
Japanese (ja)
Other versions
JPH02138268A (en
Inventor
Isao Hayakawa
Yoshiaki Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP20544089A priority Critical patent/JPH02138268A/en
Publication of JPH02138268A publication Critical patent/JPH02138268A/en
Publication of JPH0331710B2 publication Critical patent/JPH0331710B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

【発明の詳細な説明】 産業上の利用分野 本発明は抗菌性化合物の原料として有用な化合
物に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to compounds useful as raw materials for antibacterial compounds.

発明の構成 本発明は(7,8−ジフルオロ−3−メトキシ
メチル−2,3−ジヒドロ−4H−1,4−ベン
ゾオキサジン−4−イル)メチレンマロン酸ジ低
級アルキルエステルに関し、このものはピリド
[1,2,3,−de][1,4]ベンゾオキサジン
誘導体の製造原料として有用である。
Structure of the Invention The present invention relates to (7,8-difluoro-3-methoxymethyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)methylenemalonic acid di-lower alkyl ester, which is It is useful as a raw material for producing [1,2,3,-de][1,4]benzoxazine derivatives.

本発明化合物の製造法を実施例で説明する 実施例 1−(2,3−ジフルオロ−6−ニトロフエノ
キシ)−3−メトキシ−2−プロパノン9.5gをエ
タノール100mlに溶かし、ラネー・ニツケル10ml
を加えて常圧で接触還元した。触媒を濾去し、溶
媒を減圧留去後残渣をシリカゲルカラムクロマト
グラフイで精製して油状物3.9gを得た。この油
状物3.0gにエトキシメチレンマロン酸ジエチル
3.5gを加えて浴温105〜115℃で2時間加熱した。
冷後、反応物をシリカゲルカラムクロマトグラフ
イで精製し融点81℃の(7,8−ジフルオロ−3
−メトキシメチル−2,3−ジヒドロ−4H−1,
4−ベンゾオキサジン−4−イル)メチレンマロ
ン酸ジエチル4.1gを得た。
Example for explaining the method for producing the compound of the present invention by way of example 1-(2,3-difluoro-6-nitrophenoxy)-3-methoxy-2-propanone (9.5 g) was dissolved in 100 ml of ethanol, and Raney Nickel (10 ml) was dissolved in 100 ml of ethanol.
was added for catalytic reduction at normal pressure. The catalyst was filtered off, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography to obtain 3.9 g of an oil. Add 3.0g of this oil to diethyl ethoxymethylenemalonate.
3.5 g was added and heated at a bath temperature of 105 to 115°C for 2 hours.
After cooling, the reaction product was purified by silica gel column chromatography to obtain (7,8-difluoro-3
-methoxymethyl-2,3-dihydro-4H-1,
4.1 g of diethyl 4-benzoxazin-4-yl)methylenemalonate was obtained.

元素分析値 C18H21F2NO6として 計算値 C56.10,H5.49,N3.64 分析値 C56.25,H5.47,N3.74 参考例 1 2,3−ジフルオロ−6−ニトロフエノール
7.0g、エピクロルヒドリン7.0g、炭酸カリウム
15g及びヨウ化カリウム600mgをジメチルホルム
アミド150mlに加え、浴温85〜90℃で20時間撹拌
する。冷後、不溶物を濾去し、濾液を減圧濃縮し
て残渣をクロロホルムと水で分配する。クロロホ
ルム層は水洗し、芒硝で乾燥後、溶媒を留去して
残渣をシリカゲルカラムクロマトグラフイで精製
し淡黄色油状物として2,3−ジフルオロ−6−
ニトロフエニル・オキシラニルメチル・エーテル
6.1gを得た。
Elemental analysis value C 18 H 21 F 2 NO 6 Calculated value C56.10, H5.49, N3.64 Analysis value C56.25, H5.47, N3.74 Reference example 1 2,3-difluoro-6-nitro phenol
7.0g, epichlorohydrin 7.0g, potassium carbonate
15 g and 600 mg of potassium iodide are added to 150 ml of dimethylformamide and stirred for 20 hours at a bath temperature of 85-90°C. After cooling, insoluble matters were removed by filtration, the filtrate was concentrated under reduced pressure, and the residue was partitioned between chloroform and water. The chloroform layer was washed with water, dried over Glauber's salt, the solvent was distilled off, and the residue was purified by silica gel column chromatography to obtain 2,3-difluoro-6- as a pale yellow oil.
Nitrophenyl oxiranyl methyl ether
6.1g was obtained.

この化合物15.0gおよび第二塩化スズ0.3mlを
無水メタノール60mlに加えて2時間還流する。浴
媒を留去し残渣をクロロホルムと水で分配し、ク
ロロホルム層より、油状物として1−(2,3−
ジフルオロ−6−ニトロフエノキシ)−3−メト
キシ−2−プロパノール16.1gを得た。
15.0 g of this compound and 0.3 ml of tin(II) chloride were added to 60 ml of anhydrous methanol and refluxed for 2 hours. The bath medium was distilled off, the residue was partitioned between chloroform and water, and from the chloroform layer, 1-(2,3-
16.1 g of difluoro-6-nitrophenoxy)-3-methoxy-2-propanol was obtained.

この化合物15gをアセトン150mlにとかし、氷
冷下、撹拌しつつジヨーンズ試薬(無水クロム酸
32g、水64ml、濃硫酸16mlから調製)50mlを滴下
し同温度で30分、次いで室温で2時間撹拌する。
不溶物を除去し、アセトン、次いでクロロホルム
で洗つて、濾液及び洗液を合わせ溶媒を留去す
る。残渣はクロロホルムと水で分配し、クロロホ
ルム層を水洗し、芒硝で乾燥後クロロホルムを留
去する。残渣をシリカゲルカラムクロマトグラフ
イで精製し、クロロホルム溶出液から融点39〜42
℃の1−(2,3−ジフルオロ−6−ニトロフエ
ノキシ)−3−メトキシ−2−プロパノン10.6g
を得た。
Dissolve 15 g of this compound in 150 ml of acetone, stir under ice-cooling, and use Zion's reagent (chromic anhydride).
(Prepared from 32 g, 64 ml of water, and 16 ml of concentrated sulfuric acid) was added dropwise and stirred at the same temperature for 30 minutes, then at room temperature for 2 hours.
Insoluble matter is removed, washed with acetone and then with chloroform, the filtrate and washing liquid are combined, and the solvent is distilled off. The residue was partitioned between chloroform and water, the chloroform layer was washed with water, dried over Glauber's salt, and the chloroform was distilled off. The residue was purified by silica gel column chromatography and obtained from the chloroform eluate with a melting point of 39-42.
10.6 g of 1-(2,3-difluoro-6-nitrophenoxy)-3-methoxy-2-propanone at °C
I got it.

参考例 2 (7,8−ジフルオロ−3−メトキシメチル−
2,3−ジヒドロ−4H−1,4−ベンゾオキサ
ジン−4−イル)メチレンマロン酸ジエチル3.0
gをポリリン酸エチル20gに加えて浴温120〜125
℃で1.5時間加熱する。冷後、氷水を加え、析出
物をクロロホルムで抽出する。抽出液は水洗し、
芒硝乾燥後溶媒を留去する。残渣をシリカゲルカ
ラムクロマトグラフイで精製し、クロロホルム溶
出分から得られる粉末を、ジクロルメタンとイソ
プロピルエーテルの混液から再結晶して融点238
℃の微針晶として 9,10−ジフルオロ−3−メ
トキシメチル−7−オキソ−2,3−ジヒドロ−
7H−ピリド[1,2,3−de][1,4]ベンゾ
オキサジン−6−カルボン酸エチル1.7gを得た。
Reference example 2 (7,8-difluoro-3-methoxymethyl-
Diethyl 2,3-dihydro-4H-1,4-benzoxazin-4-yl)methylenemalonate 3.0
Add g to 20 g of ethyl polyphosphate and bath temperature 120-125
Heat for 1.5 hours at °C. After cooling, ice water is added and the precipitate is extracted with chloroform. Wash the extract with water,
After drying the Glauber's salt, the solvent is distilled off. The residue was purified by silica gel column chromatography, and the powder obtained from the chloroform eluate was recrystallized from a mixture of dichloromethane and isopropyl ether to give a melting point of 238.
9,10-difluoro-3-methoxymethyl-7-oxo-2,3-dihydro- as microneedles at °C
1.7 g of ethyl 7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate was obtained.

上記化合物1.7gをジクロルメタン100mlに加え
て氷冷下に臭化アルミニウム6.0gをエタンチオ
ール10mlに溶かした溶液を滴下する。室温にもど
して3時間撹拌したのち、溶媒を留去し、残渣に
氷水を加えて不溶物を濾取する。得られた白色粉
末をクロルホルムとエタノールの混液から再結晶
して融点268〜270℃の微針晶として 9.10−ジフ
ルオロ−3−ヒドロキシメチル−7−オキソ−
2,3−ジヒドロ−7H−ピリド[1,2,3−
de][1,4]ベンゾオキサジン−6−カルボン
酸エチル1.1gを得た。
1.7 g of the above compound was added to 100 ml of dichloromethane, and a solution of 6.0 g of aluminum bromide dissolved in 10 ml of ethanethiol was added dropwise under ice cooling. After returning to room temperature and stirring for 3 hours, the solvent was distilled off, ice water was added to the residue, and insoluble matter was filtered off. The obtained white powder was recrystallized from a mixture of chloroform and ethanol to give 9.10-difluoro-3-hydroxymethyl-7-oxo- as microneedles with a melting point of 268-270°C.
2,3-dihydro-7H-pyrido[1,2,3-
1.1 g of ethyl de][1,4]benzoxazine-6-carboxylate was obtained.

上記化合物400mgをクロロホルム30mlに溶かし
これに塩化チオニル3mlを加えて4時間還流し、
反応液を減圧乾固し、残渣をクロロホルムに溶か
して水、炭酸水素ナトリウム水溶液及び水で順次
洗い、芒硝で乾燥する。溶媒を留去し、残渣をク
ロロホルムとエタノールの混液から再結晶して融
点250〜251℃の微針晶として3−クロロメチル−
9,10−ジフルオロ−7−オキソ−2,3−ジヒ
ドロ−7H−ピリド[1,2,3−de][1,4]
ベンゾオキサジン−6−カルボン酸エチル220mg
を得た。
Dissolve 400 mg of the above compound in 30 ml of chloroform, add 3 ml of thionyl chloride, and reflux for 4 hours.
The reaction solution was dried under reduced pressure, and the residue was dissolved in chloroform, washed successively with water, an aqueous sodium bicarbonate solution, and water, and dried over Glauber's salt. The solvent was distilled off, and the residue was recrystallized from a mixture of chloroform and ethanol to form 3-chloromethyl-
9,10-difluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]
Ethyl benzoxazine-6-carboxylate 220mg
I got it.

上記化合物200mgを無水ベンゼン30mlに懸濁さ
せ、1,8−ジアザビシクロ[5,4,0]−7
−ウンデセン(DBU)230mgを加えて1時間還流
する。冷後反応液にクロロホルムを加えて水洗
し、芒硝乾燥後溶媒を留去し、残渣をシリカゲル
カラムクロマトグラフイで精製し、ジクロルメタ
ンとイソプロピルエーテルの混液から再結晶して
融点258〜263℃の9,10−ジフルオロ−3−メチ
レン−7−オキソ−2,3−ジヒドロ−7H−ピ
リド[1,2,3−de][1,4]−ベンゾオキ
サジン−6−カルボン酸エチル120mgを得た。
200 mg of the above compound was suspended in 30 ml of anhydrous benzene, and 1,8-diazabicyclo[5,4,0]-7
- Add 230 mg of undecene (DBU) and reflux for 1 hour. After cooling, chloroform was added to the reaction mixture and washed with water. After drying with Glauber's salt, the solvent was distilled off. The residue was purified by silica gel column chromatography, and recrystallized from a mixture of dichloromethane and isopropyl ether to give a 9. , 120 mg of ethyl 10-difluoro-3-methylene-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylate was obtained.

NMR(DMSO−d6,δppm) 3位メチレン基;5.47,5.89 (各1H,d,J=2.5Hz) 上記化合物100mgをジメチルスルホキシド3ml
に溶かし、N−メチルピペラジン100mgを加えて
浴温120〜130℃で6時間撹拌する。冷後、溶媒を
減圧乾固し、残渣をシリカゲルカラムクロマトグ
ラフイで精製する。得られた粉末100mgをエタノ
ール10mlに懸濁し、3%水酸化ナトリウム水溶液
1mlを加えて40〜50℃で30分間撹拌する。反応液
を減圧乾固し、残渣に水を加えて希塩酸で酸性と
したのち再び炭酸水素ナトリウムで塩基性とし、
クロロホルムで抽出する。抽出液は芒硝で乾燥
し、溶媒を留去する。残渣をシリカゲルカラムク
ロマトグラフイで精製し、エタノールから再結晶
して融点200〜201℃の微針晶として9−フルオロ
−10−(4−メチル−1−ピペラジニル)−3−メ
チレン−7−オキソ−2,3−ジヒドロ−7H−
ピリド[1,2,3−de][1,4]ベンゾオキ
サジン−6−カルボン酸25mgを得た。
NMR (DMSO-d 6 , δppm) Methylene group at 3-position; 5.47, 5.89 (1H, d, J = 2.5Hz each) 100mg of the above compound was dissolved in 3ml of dimethyl sulfoxide.
Add 100 mg of N-methylpiperazine and stir at a bath temperature of 120-130°C for 6 hours. After cooling, the solvent is dried under reduced pressure, and the residue is purified by silica gel column chromatography. 100 mg of the obtained powder is suspended in 10 ml of ethanol, 1 ml of 3% aqueous sodium hydroxide solution is added, and the mixture is stirred at 40 to 50°C for 30 minutes. The reaction solution was dried under reduced pressure, water was added to the residue, acidified with dilute hydrochloric acid, and then made basic again with sodium hydrogen carbonate.
Extract with chloroform. The extract was dried with Glauber's salt and the solvent was distilled off. The residue was purified by silica gel column chromatography and recrystallized from ethanol to give 9-fluoro-10-(4-methyl-1-piperazinyl)-3-methylene-7-oxo as microneedles with a melting point of 200-201°C. -2,3-dihydro-7H-
25 mg of pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid was obtained.

NMR(CDCl3,δppm) 4.83(2H,s,2位CH2) 5.26,5.61((各1H,d,J=3.0Hz,3位
C=CH2) 8.83(1H,s,5位 H) 7.63(1H,d,J=12Hz,8位H)
NMR (CDCl 3 , δppm) 4.83 (2H, s, 2nd place CH 2 ) 5.26, 5.61 ((each 1H, d, J = 3.0Hz, 3rd place
C=CH 2 ) 8.83 (1H, s, 5th H) 7.63 (1H, d, J=12Hz, 8th H)

Claims (1)

【特許請求の範囲】 1 式 (式中R1は低級アルキル基を意味する) で表わされる化合物。 2 (7,8−ジフルオロ−3−メトキシメチル
−2,3−ジヒドロ−4H−1,4−ベンゾオキ
サジン−4−イル)メチレンマロン酸ジエチルで
ある特許請求の範囲第1項の化合物。
[Claims] 1 formula (In the formula, R 1 means a lower alkyl group.) A compound represented by: 2. The compound of claim 1 which is diethyl (7,8-difluoro-3-methoxymethyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)methylenemalonate.
JP20544089A 1989-08-08 1989-08-08 Benzoxazine compound Granted JPH02138268A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20544089A JPH02138268A (en) 1989-08-08 1989-08-08 Benzoxazine compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20544089A JPH02138268A (en) 1989-08-08 1989-08-08 Benzoxazine compound

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP57112040A Division JPS591489A (en) 1982-06-29 1982-06-29 Pyridobenzoxazine derivative

Publications (2)

Publication Number Publication Date
JPH02138268A JPH02138268A (en) 1990-05-28
JPH0331710B2 true JPH0331710B2 (en) 1991-05-08

Family

ID=16506912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20544089A Granted JPH02138268A (en) 1989-08-08 1989-08-08 Benzoxazine compound

Country Status (1)

Country Link
JP (1) JPH02138268A (en)

Also Published As

Publication number Publication date
JPH02138268A (en) 1990-05-28

Similar Documents

Publication Publication Date Title
US4777253A (en) Process for preparation of racemate and optically active ofloxacin and related derivatives
JPH0566945B2 (en)
FI91070C (en) Improvement in the synthesis of 6-methylene derivatives of androsta-1,4-diene-3,17-dione
KR0125115B1 (en) Method for preparing (-) piperazine benzoxazine derivative
JPH0148911B2 (en)
JPH027314B2 (en)
JPS62252790A (en) Pyridobenzoxazine derivative
KR900004145B1 (en) Process for preparation of tricyclic compounds
JPH0331710B2 (en)
CZ294957B6 (en) Process for preparing a substituted imidazopyridine compound
JPH0518816B2 (en)
JPH0116837B2 (en)
JPH0317838B2 (en)
CS202069B2 (en) Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines
WO2000015596A1 (en) Processes for the preparation of fluorinated benzoic acids
JPWO2000015596A1 (en) Method for producing fluorine-substituted benzoic acids
KR100248370B1 (en) Preparation of intermediate of (-)-3(s)-methylpyrido benzoxizine derivative
JPS6257636B2 (en)
KR960010351B1 (en) Method for preparing benzoxazine derivatives
KR0128029B1 (en) Method for preparing benzoxazine carboxylic acid derivative
DK158268B (en) Procedure for production of pyridobenzoxazine-derivatives
JP4055246B2 (en) 5-chloro-6- (α-fluoroalkyl) -4-pyrimidone and process for producing the same
JPS61246172A (en) Benzoxazinylmalonic acid derivative
JPS6256154B2 (en)
JPS61271292A (en) 3-fluoromethyl-pyridobenzoxazine derivative

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19911112